Search results for " effect"

showing 10 items of 7524 documents

Pharmacokinetic and clinical evaluation of esomeprazole and ASA for the prevention of gastroduodenal ulcers in cardiovascular patients.

2012

Low-dose aspirin (ASA, 75 - 325 mg/day) is widely used for the primary and secondary prevention of cardiovascular (CV) diseases. However, the value of primary prevention ASA is uncertain as the reduction in occlusive events needs to be weighed against the significant increase in major bleedings. Prevention with antisecretory drugs has been proposed to reduce the incidence of ASA-induced gastrointestinal (GI) bleedings, but non-adherence to gastro-protection is of concern, as it significantly increases the risk of upper GI adverse events. Beside patients and physicians education, one approach to overcome non-adherence is the development of fixed-dose combination.This review explores the resu…

medicine.medical_specialtyPeptic UlcerToxicologyGastroenterologyEsomeprazolePharmacokineticsInternal medicinemedicineHumansIn patientDrug InteractionsAdverse effectRandomized Controlled Trials as TopicPharmacologyAspirinAspirinbusiness.industryIncidence (epidemiology)EsomeprazoleGeneral MedicineAnti-Ulcer Agentsdigestive system diseasesGastroduodenal ulcerCardiovascular DiseasesbusinessClinical evaluationPlatelet Aggregation Inhibitorsmedicine.drugExpert opinion on drug metabolismtoxicology
researchProduct

Efficacy of DiscoGel in Treatment of Degenerative Disc Disease: A Prospective 1-Year Observation of 67 Patients

2021

Patients with degenerative disc disease may suffer from chronic lumbar discogenic (DP) or radicular leg (RLP) pain. Minimally invasive DiscoGel therapy involves the percutaneous injection of an ethanol gel into the degenerated disk’s nucleus pulposus. This paper compares the 1-year outcome of such treatment in DP and RLP patients. We operated on 67 patients (49 men and 18 women) aged 20–68 years (mean age 46 ± 11 years) with DP (n = 45) and RLP (n = 22), of at least 6–8 weeks duration, with no adverse effects. We evaluated the treatment outcome with Core Outcome Measures Index (COMI) and Visual Analog Scale (VAS). A year after the ethanol gel injection, in the DP cohort, COMI and VAS droppe…

medicine.medical_specialtyPercutaneousVisual analogue scaleNeurosciences. Biological psychiatry. NeuropsychiatryArticleDegenerative disc diseaseLumbarMedicineethanol gelAdverse effectradiculopathylow back painpercutaneous spine surgeryCore (anatomy)business.industryGeneral Neurosciencediscogenic painchemonucleolysis; discogenic pain; ethanol gel; low back pain; percutaneous spine surgery; radiculopathymedicine.diseaseLow back painSurgerychemonucleolysisCohortmedicine.symptombusinessRC321-571Brain Sciences
researchProduct

TCT-282 Risk Factors Associated with Adverse Events during Chronic Total Occlusion Percutaneous Coronary Interventions: A sub-Analysis of the OPEN-CT…

2016

Coronary chronic total occlusions (CTOs) are prevalent and the development of the hybrid approach to CTO PCI has been associated with increased technical success rates. However, the incidence and predictors of adverse events (AEs) during CTO PCI remains poorly defined. We analyzed baseline patient

medicine.medical_specialtyPercutaneousbusiness.industryIncidence (epidemiology)Technical successPsychological intervention030204 cardiovascular system & hematologyHybrid approachTotal occlusion03 medical and health sciencessurgical procedures operative0302 clinical medicineInternal medicineConventional PCImedicineCardiologycardiovascular diseases030212 general & internal medicineCardiology and Cardiovascular MedicineAdverse effectbusinessJournal of the American College of Cardiology
researchProduct

The percutaneous treatment of Patent Foramen Ovale, an effective and safe therapeutic choice

2013

Introduction: The aim of our study is to evaluate the feasibility, safety and efficacy of the percutaneous closure of PFO (abnormal communication between the right and left atrium). Methods: Between July 2009 and October 2012 percutaneous closure was performed in 37 patients. The presence of PFO was diagnosed through the use of ultrasound techniques: transcranial doppler with contrast (cTCD), transthoracic echocardiography(TTE) and transesophageal echocardiography (TEE). Follow-up was composed consisted of a Holter ECG 7 days after the closure with a 24 hour heart rhythm monitoring, to evaluate eventual arrhythmia cases and programmed controls which included a TTE at 1-3 months, TTE+ cTCD a…

medicine.medical_specialtyPercutaneousbusiness.industryMedicine (all)patent foramen ovaleRGeneral Medicinemedicine.diseaseNew onset atrial fibrillationTranscranial DopplerSurgeryUltrasound techniquespercutaneous closuremedicine.anatomical_structurePfo closureInternal medicinemedicineCardiologyPatent foramen ovalecryptogenic strokeMedicineAdverse effectbusinessInteratrial septumOpen Medicine
researchProduct

Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System

2021

Purpose: This study investigated the 2-year safety and effectiveness of the PQ Bypass DETOUR system as a percutaneous femoropopliteal bypass. Materials and Methods: Seventy-eight patients with 82 long-segment femoropopliteal lesions were enrolled in this prospective, single-arm, multicenter study. The DETOUR system deployed Torus stent grafts directed through a transvenous route. Eligible patients included those with lesions of >10 cm and average of 371±55 mm. Key safety endpoints included major adverse events (MAEs) and symptomatic deep venous thrombosis in the target limb. Effectiveness endpoints included primary patency defined as freedom from ≥50% stenosis, occlusion, or clinically-d…

medicine.medical_specialtyPercutaneousmedicine.medical_treatmentLesionPeripheral Arterial DiseaseOcclusionmedicineHumansPopliteal ArteryRadiology Nuclear Medicine and imagingProspective StudiesAdverse effectVascular Patencybusiness.industryEndovascular ProceduresStentmedicine.diseaseSurgeryFemoral ArteryVenous thrombosisStenosisTreatment OutcomeStentsSurgerymedicine.symptomCardiology and Cardiovascular MedicinebusinessClaudicationJournal of Endovascular Therapy
researchProduct

Cytoreductive surgery and mitomycin C hyperthermic intraperitoneal chemotherapy with CO2 recirculation (HIPEC-CO2) for colorectal cancer peritoneal m…

2021

Peritoneal dissemination from colorectal cancer (CRC) has long been associated with unfavorable prognosis. However, in the last decades, the combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) was able to obtain up to 30% 5-year survival rate in selected centers. Despite the wide diffusion of CRS and HIPEC, until now, there are no clear recommendations on the drug of choice for HIPEC nor its technique, and safety and efficacy data of HIPEC regimens and techniques are lacking. We performed a retrospective analysis of a prospectively maintained database of 26 CRS and mitomycin C HIPEC with CO2 recirculation (HIPEC-CO2) for CRC peritoneal metastasis…

medicine.medical_specialtyPeritoneal metastasisColorectal cancerMitomycinSettore MED/18 - CHIRURGIA GENERALE2Hyperthermic Intraperitoneal Chemotherapy030230 surgery03 medical and health sciences0302 clinical medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansHyperthermiaAdverse effectSurvival ratePeritoneal NeoplasmsRetrospective StudiesCarcinomatosisHIPECbusiness.industryInducedMitomycin CCommon Terminology Criteria for Adverse EventsCytoreduction Surgical ProceduresHyperthermia InducedCarbon DioxidePrognosismedicine.diseaseColorectal cancerCombined Modality TherapyHIPEC-COSurgerySurvival Rate030220 oncology & carcinogenesisPeritoneal metastasisSurgeryHyperthermic intraperitoneal chemotherapyColorectal NeoplasmsbusinessCytoreductive surgeryUpdates in Surgery
researchProduct

A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic ha…

2021

BACKGROUND: Cytomegalovirus (CMV) is a complication of allogeneic haematopoietic cell transplantation (allo-HCT). ASP0113, a DNA-based vaccine, contains two plasmids encoding human CMV glycoprotein B and phosphoprotein 65 (pp65). We assessed ASP0113 in CMV-seropositive allo-HCT recipients. METHODS: In this phase 3, randomised, placebo-controlled study, CMV-seropositive allo-HCT recipients were randomly assigned (1:1) via interactive response technology to receive five injections of 1 mL of 5 mg/mL ASP0113 or placebo. The pharmacist and designated staff were unblinded. Masked syringes maintained the blind for patients and study personnel. Efficacy and safety analyses included patients who re…

medicine.medical_specialtyPhases of clinical research[SDV.CAN]Life Sciences [q-bio]/CancerDiseaseGANCICLOVIRPlacebo01 natural sciencesPROPHYLAXIS03 medical and health sciencesDOUBLE-BLIND0302 clinical medicineMedicine General & Internal[SDV.CAN] Life Sciences [q-bio]/CancerInternal medicineGeneral & Internal MedicinemedicineCYTOMEGALOVIRUS DISEASE030212 general & internal medicine0101 mathematicsAdverse effectlcsh:R5-920Science & Technologybusiness.industryIncidence (epidemiology)010102 general mathematicsGeneral MedicineOdds ratioConfidence interval3. Good healthbusinessComplicationlcsh:Medicine (General)Life Sciences & BiomedicineResearch PaperEClinicalMedicine
researchProduct

Beneficial Effects of Inspiratory Muscle Training Combined With Multicomponent Training in Elderly Active Women

2019

ABSTRACTPurpose: This study aims to analyze changes in Maximum Inspiratory Pressure (MIP), lung function, cardiorespiratory fitness, and blood pressure, in 10 healthy active elderly women, followin...

medicine.medical_specialtyPhysical fitnessBlood Pressure030209 endocrinology & metabolismPhysical Therapy Sports Therapy and RehabilitationPhysical strengthBreathing Exercises03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationHumansMedicineOrthopedics and Sports MedicineMuscle StrengthCardiovascular fitnessBeneficial effectsLung functionAgedbusiness.industryInspiratory muscle trainingCardiorespiratory fitness030229 sport sciencesGeneral MedicineRespiratory MusclesBlood pressureCardiorespiratory FitnessInhalationNephrologyFemalesense organsbusinessPhysical Conditioning HumanResearch Quarterly for Exercise and Sport
researchProduct

Cardiorespiratory Coordination after Training and Detraining. A Principal Component Analysis Approach

2016

Our purpose was to study the effects of different training modalities and detraining on cardiorespiratory coordination (CRC). Thirty-two young males were randomly assigned to four training groups: aerobic (AT), resistance (RT), aerobic plus resistance (AT + RT), and control (C). They were assessed before training, after training (6 weeks) and after detraining (3 weeks) by means of a graded maximal test. A principal component (PC) analysis of selected cardiovascular and cardiorespiratory variables was performed to evaluate CRC. The first PC (PC1) coefficient of congruence in the three conditions (before training, after training and after detraining) was compared between groups. Two PCs were …

medicine.medical_specialtyPhysiologySpeech recognitioneducationphysiological variableslcsh:PhysiologyMalalties de l'aparell respiratori03 medical and health sciences0302 clinical medicinePhysiology (medical)MedicineCardiorespiratory exercise testingTraining programmeYoung maleOriginal Researchcomplex adaptive systemsTraining periodPrincipal Component AnalysisCoordinative variableslcsh:QP1-981business.industryCardiorespiratory fitnessRespiratory organs diseases030229 sport sciencesStrength variablesPrincipal component analysisPhysical therapybusiness030217 neurology & neurosurgerytraining effects
researchProduct

Direct and surrogate measures of the white-coat effect: Methodological aspects and clinical relevance

2000

medicine.medical_specialtyPhysiologybusiness.industryOffice VisitsOffice visitsMEDLINEBlood Pressure DeterminationPrognosisOrgan damageBlood pressureAmbulatoryHypertensionInternal MedicineMedicineHumansClinical significanceOffice VisitCardiology and Cardiovascular MedicinebusinessIntensive care medicineWhite coat effectHuman
researchProduct